facebook
24/7 Market News
EMMA
EMMAUS LIFE SCIENCES INC NEW
Other OTC
$1.64
$0.0700
4.09%
EMMAUS LIFE SCIENCES INC NEW
Status: Active
Sector: Healthcare
Industry: Biotechnology
Symbol: EMMA
Exchange: PNK
Employees: 56
Emmaus Life Sciences, Inc. engages in the discovery, development, and commercialization of treatments and therapies primarily for rare and orphan diseases in the United States and internationally. It provides Endari, which is L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Emmaus Life Sciences, Inc. has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California.
EMMAUS LIFE SCIENCES INC NEW
PNK
Healthcare
Biotechnology
21250 Hawthorne Boulevard, Torrance, CA, United States
United States
310 214 0065
http://www.emmausmedical.com

    NEWS



    Dear Market Participant,

    As the year is closing out and stocks hitting new highs, we have 2 exciting reports that are ready for you!

    These “UNDERVALUED” companies are trending upward, in the hottest market sectors, and deserve your immediate attention.
    One company is a smart Bio-Pharma that’s expected to eclipse $30 million in annual revenues, as they roll out their newly approved drug. Plus, they’re working on opening new and much richer market applications.
    The other one is an Aerospace incubator that’s looking to make its mark in the exciting “VTOL” space with the sharpest coolest “Air Taxi” designs you’ll ever see.
    Both reports contain valuable timely information, which could make my readers thousands in profits and help you to continue to enjoy unprecedented gains in today’s market.

    If you’re interested in making money in the market, you’ll want to read about these companies first, read the report below.

     

    MAKE SURE YOU CONTINUE GETTING OUR

    STOCK MARKET UPDATES

    It won't cost you anything!​

    …and we promise they’re an easy read that’s worth your time.

    Our reports focus on companies that are expecting significant news events, which we believe will become catalysts for vertical growth and market appreciation.
    Our editorials focus on disruptive technologies that are poised to become leaders in their respective industries in the small to mid-cap market spaces.
    Thank you!
    Editor
    24/7 MarketNews
    © 2020 24/7MarketNews | All Rights Reserved
    Send this to a friend
    Hi, this may be interesting you: Stock Prices & Marketcap! This is the link: https://www.247marketnews.com/stock-prices-marketcap/